Published on 22 Dec 2023 on GuruFocus.com via Yahoo Finance
CFO Houte Van Sells 10,906 Shares of Nurix Therapeutics Inc
On December 19, 2023, Houte Van, the CFO of Nurix Therapeutics Inc (NASDAQ:NRIX), executed a sale of 10,906 shares in the company, according to a recent SEC Filing. This transaction was carried out with the shares priced at $10 each, resulting in a total sale value of $109,060.
Warning! GuruFocus has detected 3 Warning Signs with NRIX.
Nurix Therapeutics Inc is a biopharmaceutical company focused on the discovery, development, and commercialization of small molecule therapies designed to modulate cellular protein levels as a novel treatment approach for cancer and immune disorders.